A Phase I/II trial of HMI-102 for phenylketonuria (PKU)
Phase of Trial: Phase I/II
Latest Information Update: 07 Jan 2019
At a glance
- Drugs HMI-102 (Primary)
- Indications Phenylketonuria
- Focus Adverse reactions; Therapeutic Use
- 07 Jan 2019 According to a Homology Medicines media release, the company expects to start this study in 2019 with initial data expected by year-end of 2019.
- 05 Jul 2018 According to a Homology Medicines media release, the company expects to present initial data from this study in 2019.
- 25 May 2018 New trial record